Question follow-through · 118726

Fampridine

To ask the Secretary of State for Health and Social Care, whether he has made a comparative assessment of the adequacy of availability of fampridine (fampyra) for patients across the four nations of the UK.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body: Department of Health and Social Care
Tabled: 9 Mar 2026
Target answer date: 11 Mar 2026
Answer: 18 Mar 2026 · 9 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

Votes on this topic

Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
Health Bill: Report Stage: New Clause 143 · 8 Sept 2026

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

9 Mar 2026
Question tabled
To ask the Secretary of State for Health and Social Care, whether he has made a comparative assessment of the adequacy of availability of fampridine (fampyra) for patients across the four nations of the UK.
11 Mar 2026
Target answer date
Date supplied by the official written-questions record.
18 Mar 2026
Answer published
Health is a devolved matter and decisions on the availability of medicines in the devolved administrations are a matter for their own governments.Ministers and Department officials have had no recent discussions with the National Institute for Health and ...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.